ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia

Autor: O`Neill, M. J., Murray, T. K., McCarty, D. R., Hicks, C. A., Dell, C. P., Patrick, K. E., Ward, M. A., Osborne, D. J., Wiernicki, T. R., Roman, C. R.

Publikováno v: Brain Research; 2000, Vol. 871 Issue: 2 p234-244, 11p

ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia.

Autor: O'Neill MJ; Eli Lilly and Co. Ltd., Lilly Research Centre, Erl Wood Manor, Windlesham, GU20 6PH, Surrey, UK. oneill_michael_j@lilly.com, Murray TK, McCarty DR, Hicks CA, Dell CP, Patrick KE, Ward MA, Osborne DJ, Wiernicki TR, Roman CR, Lodge D, Fleisch JH, Singh J

Publikováno v: Brain research [Brain Res] 2000 Jul 21; Vol. 871 (2), pp. 234-44.

Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty.

Autor: Singh JP; Eli Lilly and Company, Indianapolis, Indiana., Rothfuss KJ, Wiernicki TR, Lacefield WB, Kurtz WL, Brown RF, Brune KA, Bailey D, Dubé GP

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 1994 Mar 01; Vol. 23 (3), pp. 665-71.